Borderline BE study Failure [Study As­sess­ment]

posted by jag009  – NJ, 2014-10-14 18:59 (3862 d 07:25 ago) – Posting: # 13705
Views: 6,909

Agree with Bloom,

Better to reformulate since your T/R ratios are way too low.

Question:

❝ For Product X (IR tablets), full replicated BE study was performed on 56 volunteers under fasting state (EU submission).


Why did you run a full replicate study? Based on your data the drug doesn't look like a HVD (unless your pilot data suggested)

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
115 visitors (0 registered, 115 guests [including 11 identified bots]).
Forum time: 02:24 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5